Clinical Trials Sponsored by Innovex, Inc

Total 35614 results

Pfizer
Innovex, Inc

Completed

Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

Rheumatoid Arthritis

Luxembourg
Innovus Pharmaceuticals, Inc.

Unknown

An Open Label Study to Assess the Effect of Euryco-10® Oral Dietary Supplement in Senior Men

Healthy Aging

United States
Innovus Pharmaceuticals, Inc.

Unknown

A Study to Evaluate the Effect and Tolerance of Musclin™ (Thymol) in Healthy Subjects

Healthy Volunteers

United States
Innovo Therapeutics, Inc.

Recruiting

Ointment to Prevent Scar After Thyroidectomy

Scar

Korea, Republic of
Innovo Therapeutics, Inc.

Completed

First in Human, Single Ascending Dose Study

Ulcerative Colitis

Korea, Republic of
Innova Vascular, Inc.

Not yet recruiting

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) (TRUST)

Pulmonary Embolism
Epigenomics, Inc
Innovis LLC

Completed

HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Cirrhosis, Liver | Liver Cancer | Hepatic Cirrhosis

United States
Innovis LLC
Ajinomoto Co., Inc.

Completed

A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology

Lung Cancer

United States
Innovent Biologics (Suzhou) Co. Ltd.
Innovent Biologics (USA), Inc.

Withdrawn

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

Metastatic Cutaneous Melanoma | Unresectable Cutaneous Melanoma

United States, Germany, France, Australia, Spain, Switzerland, United Kingdom
InnoVec Biotherapeutics Inc.
Peking Union Medical College Hospital

Not yet recruiting

Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis

Eye Diseases | Retinal Degeneration | Retinal Disease | Retinoschisis

China
Zhejiang Cancer Hospital
Innovent Biologics, Inc.

Recruiting

A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric Cancer

Unresectable Gastric Cancer

China
InnoMed Healthscience Inc.
RVW Clinical Consulting

Terminated

Clinical Study for the BONGO NASAL Expiratory Positive Airway Pressure (EPAP) Device in the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea

United States
Long Island University
BROOKLYN INNOSEQ INC.

Recruiting

Gestational Diabetes Mellitus (GDM) in Pregnant Women

Pregnancy Complications | Gestational Diabetes Mellitus

United States
InnoMed Healthscience Inc.
RVW Clinical Consulting

Completed

Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea

United States
InnoVein

Recruiting

Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency

Chronic Venous Insufficiency

Australia
Sun Yat-sen University
Innovent Biologics, Inc.

Active, not recruiting

HAIC Combined With PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC (HAICPD1-HCC)

Hepatocellular Carcinoma

China
Otsuka Pharmaceutical Development & Commercialization...
i3 Innovus

Completed

Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)

Depressive Disorder, Major
Innodem Neurosciences

Not yet recruiting

Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis

Multiple Sclerosis

Canada
Innodem Neurosciences

Recruiting

Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

Multiple Sclerosis

Canada
Innodem Neurosciences

Recruiting

Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)

Cancer-related Cognitive Impairment

Canada
Innodem Neurosciences

Recruiting

Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease

Alzheimer's Disease

Canada
Zhejiang Cancer Hospital
Akeso; Innovent Biologics, Inc.

Not yet recruiting

A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer

Vulvar and Vaginal Cancer

China
Innodem Neurosciences

Suspended

Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders

Neurological Disorders

Canada
Xiamen Innovax Biotech Co., Ltd

Completed

A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)

Hepatitis E

China
Xiamen Innovax Biotech Co., Ltd

Completed

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)

Hepatitis B | Hepatitis E

China
Xiamen Innovax Biotech Co., Ltd

Completed

Immunogenicity and Safety of One Dose of HPV Vaccine

Human Papillomavirus Vaccines

China
Xiamen Innovax Biotech Co., Ltd

Completed

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )

Hepatitis E

China
University of Nairobi
Consortium for Advanced Research Training in Africa (CARTA); Innovix Pharma...

Completed

Omega-3 Supplementation and Depression Clinical Trial

Depressive Symptoms

Kenya
AstraZeneca
i3 Innovus

Completed

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France (REMAIN)

Gastroesophageal Reflux Disease

France
AstraZeneca
i3 Innovus

Completed

Observational Study on Costs and Caregiver Burden in Alzheimer's Disease

Alzheimer's Disease

Sweden, United States, Spain, United Kingdom
China National Center for Cardiovascular Diseases
Innovent Biologics, Inc.

Not yet recruiting

Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population

Acute Coronary Syndrome | Non ST Segment Elevation Acute Coronary Syndrome
Sichuan Cancer Hospital and Research Institute
Innovent Biologics, Inc.

Unknown

Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC

Neoplasms | Respiratory Tract Diseases | Lung Diseases | Thoracic Neoplasms | Non-small-cell Lung Cancer
AltheaDx
Innovis LLC

Completed

Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety

Depression | Anxiety

United States
AstraZeneca
i3 Innovus

Completed

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US (REMAIN)

Gastroesophageal Reflux Disease (GERD)

United States
Innodem Neurosciences
Syneos Health

Recruiting

ETNA-MS Device Validation Study (ETNA-MS)

Multiple Sclerosis

United States
Innodem Neurosciences
Novartis Pharmaceuticals

Recruiting

Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis

Multiple Sclerosis

Canada
McGill University
Innodem Neurosciences

Recruiting

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

Clinically Isolated Syndrome | Relapsing Remitting Multiple Sclerosis

Canada
Bio-innova Co., Ltd

Not yet recruiting

Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg

Healthy Subjects
Bio-innova Co., Ltd

Recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

Healthy Subjects

Thailand
Bio-innova Co., Ltd

Not yet recruiting

Desogestrel Tablets (0.075 mg) Relative to Originator Desogestrel Tablets (0.075 mg)

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg

Healthy Subjects
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Locally Advanced Solid Tumor

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics

Asthma | Healthy Participants

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics

Psoriasis

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Solid Tumor

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based Chemotherapy and Pemetrexed in Subjects With CEACAM5 Positive Expression Advanced/Metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

Non-squamous Non-small-cell Lung Cancer

China
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

A First-in-human Study of IBI354 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Locally Advanced Unresectable or Metastatic Solid Tumors

Australia

3

Subscribe